Web Results

paratekpharma.com

Paratek Pharmaceuticals (NASDAQ: PRTK) is a biopharmaceutical company that develops transformative solutions for patients, both in and out of the hospital, ...

www.fiercebiotech.com/financials/paratek-absorbs-troubled-transcept-a-reverse-merger

Jul 1, 2014 ... ... a reverse merger with the struggling Transcept Pharmaceuticals and ... Pending shareholder approval, the combined company will set out ...

globenewswire.com/news-release/2014/10/30/678340/10105511/en/Paratek-Pharmaceuticals-Completes-Merger-With-Transcept-Pharmaceuticals.html

Oct 30, 2014 ... BOSTON, Oct. 30, 2014 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. ( Nasdaq:PRTK) and Transcept Pharmaceuticals, Inc.

www.prnewswire.com/news-releases/transcept-pharmaceuticals-and-paratek-pharmaceuticals-sign-merger-agreement-265348211.html

Jul 1, 2014 ... Merger to result in NASDAQ-listed biopharmaceutical company whose lead asset is a novel Phase 3-ready, oral and intravenous antibiotic ...

www.transcept.com

transcept.com. Get all of the latest information on transcept.com at www.transcept .com.

www.sec.gov/Archives/edgar/data/1178711/000119312514325793/d778634ds4.htm

Transcept Pharmaceuticals, Inc. (“Transcept”) and Paratek Pharmaceuticals, Inc. (“Paratek”) have entered into an Agreement and Plan of Merger and ...

www.linkedin.com/company/transcept-pharmaceuticals-inc-

Learn about working at Transcept Pharmaceuticals, Inc.. Join LinkedIn today for free. See who you know at Transcept Pharmaceuticals, Inc., leverage your ...

www.biospace.com/company_profile.aspx?CompanyId=541319

Nov 1, 2007 ... Novacea, Inc. (Acquired by Transcept Pharmaceuticals, Inc.) 400 Oyster Point Boulevard Suite 200. South San Francisco California 94080 ...

www.drugs.com/manufacturer/transcept-pharmaceuticals-inc-142.html

Pharmaceutical company profile for Transcept Pharmaceuticals, Inc.